Extendicare (TSE:EXE – Get Free Report) had its price objective boosted by equities research analysts at TD Securities from C$15.00 to C$19.00 in a note issued to investors on Thursday,BayStreet.CA reports. TD Securities’ price objective would suggest a potential downside of 0.05% from the stock’s previous close.
Several other brokerages also recently weighed in on EXE. National Bankshares lifted their target price on shares of Extendicare from C$16.10 to C$17.50 and gave the company an “outperform” rating in a report on Wednesday, October 8th. National Bank Financial raised shares of Extendicare to a “strong-buy” rating in a report on Wednesday, July 16th. Cibc World Mkts raised shares of Extendicare to a “strong-buy” rating in a report on Monday, September 22nd. Finally, CIBC set a C$18.00 price target on Extendicare and gave the stock an “outperform” rating in a research note on Monday, September 22nd. Two investment analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of C$16.80.
Check Out Our Latest Stock Analysis on Extendicare
Extendicare Stock Performance
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- What is a support level?
- AMD to $300 Looks Easy—Here’s Why $500 Could Be Next
- NYSE Stocks Give Investors a Variety of Quality Options
- $5B+ in Buybacks: What DraftKings, AppLovin, and Altria Are Telling You
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 4 High-Yield Real Estate Stocks to Buy as Investors Get Defensive
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
